[Health care of chronic inflammatory skin diseases : Do affected individuals seek dermatological care?]
Versorgung von chronisch entzündlichen Hauterkrankungen : Gehen Betroffene zum niedergelassenen Dermatologen?
Atopic eczema
Health service research
Patient-centered care
Psoriasis
Urticaria
Journal
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
ISSN: 1432-1173
Titre abrégé: Hautarzt
Pays: Germany
ID NLM: 0372755
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
pubmed:
29
9
2019
medline:
20
11
2019
entrez:
28
9
2019
Statut:
ppublish
Résumé
Psoriasis, atopic eczema and urticaria are chronic inflammatory skin diseases that are often associated with an impairment of affected individuals and their families. Despite constant progress in therapy of these diseases, affected people often do not consult an office-based dermatologist. The aim of this study was to estimate which proportion of affected individuals with severe forms of these diseases receive treatment by an office-based dermatologist in Bavaria. All dermatologists listed in the database of the Bavarian Association of Panel Doctors (KVB; Kassenärztliche Vereinigung Bayern; n = 499) were invited to participate in a paper-based cross-sectional study. The stated number of patients by each dermatologist were set in relation with the literature-based 1‑year prevalence, as well as data on population and data of the KVB. Estimations were based on three approaches (conservative, medium, and progressive estimation method). Overall, 137 dermatologists participated (38.7% women; mean age: 53.2 ± 8.5 years). Conservative estimation indicated that 56.5% of individuals with moderate to severe psoriasis, 57.3% of individuals with moderate to severe atopic eczema and 71.9% of those suffering from chronic spontaneous urticaria are not seen by an office-based dermatologist. Many affected individuals seem not to seek an office-based dermatologist when affected by a severe skin condition. Thus, further and more precise studies to identify, address and minimize barriers to optimal patient care are needed.
Sections du résumé
BACKGROUND
BACKGROUND
Psoriasis, atopic eczema and urticaria are chronic inflammatory skin diseases that are often associated with an impairment of affected individuals and their families. Despite constant progress in therapy of these diseases, affected people often do not consult an office-based dermatologist.
OBJECTIVES
OBJECTIVE
The aim of this study was to estimate which proportion of affected individuals with severe forms of these diseases receive treatment by an office-based dermatologist in Bavaria.
MATERIALS AND METHODS
METHODS
All dermatologists listed in the database of the Bavarian Association of Panel Doctors (KVB; Kassenärztliche Vereinigung Bayern; n = 499) were invited to participate in a paper-based cross-sectional study. The stated number of patients by each dermatologist were set in relation with the literature-based 1‑year prevalence, as well as data on population and data of the KVB. Estimations were based on three approaches (conservative, medium, and progressive estimation method).
RESULTS
RESULTS
Overall, 137 dermatologists participated (38.7% women; mean age: 53.2 ± 8.5 years). Conservative estimation indicated that 56.5% of individuals with moderate to severe psoriasis, 57.3% of individuals with moderate to severe atopic eczema and 71.9% of those suffering from chronic spontaneous urticaria are not seen by an office-based dermatologist.
CONCLUSION
CONCLUSIONS
Many affected individuals seem not to seek an office-based dermatologist when affected by a severe skin condition. Thus, further and more precise studies to identify, address and minimize barriers to optimal patient care are needed.
Identifiants
pubmed: 31560083
doi: 10.1007/s00105-019-04481-6
pii: 10.1007/s00105-019-04481-6
doi:
Types de publication
Journal Article
Langues
ger
Sous-ensembles de citation
IM
Pagination
875-882Références
Gesundheitswesen. 2019 Jan;81(1):50-57
pubmed: 27756084
J Dtsch Dermatol Ges. 2016 Jan;14(1):e1-75
pubmed: 26713660
Clin Exp Dermatol. 2010 Dec;35(8):869-73
pubmed: 20456386
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1331-1340
pubmed: 31002197
J Eur Acad Dermatol Venereol. 2016 Apr;30(4):569-75
pubmed: 26538533
Allergy. 2017 Dec;72(12):2005-2016
pubmed: 28543019
Hautarzt. 2019 Jul;70(7):520-526
pubmed: 31134287
BMC Dermatol. 2015 Mar 14;15:4
pubmed: 25887502
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):205-212
pubmed: 27573025
J Dtsch Dermatol Ges. 2014 Jan;12(1):48-57
pubmed: 24393314
Allergy. 2018 Jun;73(6):1284-1293
pubmed: 29319189
J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1308-1315
pubmed: 28281329
J Dtsch Dermatol Ges. 2018 May;16(5):645-669
pubmed: 29750443
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1421-1428
pubmed: 30891839
Dermatology. 2008;216(4):366-72
pubmed: 18319601
Br J Gen Pract. 2014 Aug;64(625):380-1
pubmed: 25071029
J Dtsch Dermatol Ges. 2010 Jul;8(7):516-24
pubmed: 20163501
Hautarzt. 2018 Oct;69(10):801-808
pubmed: 30116831
Arch Dermatol Res. 2016 Aug;308(6):389-400
pubmed: 27048503
J Dtsch Dermatol Ges. 2012 Sep;10(9):648-55
pubmed: 22525221
Hautarzt. 2018 Oct;69(10):815-824
pubmed: 30191254
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):978-984
pubmed: 29356181
J Dtsch Dermatol Ges. 2013 Oct;11(10):965-6
pubmed: 26227351
J Am Acad Dermatol. 2019 Jun;80(6):1556-1563
pubmed: 30171876
J Dtsch Dermatol Ges. 2017 Dec;15(12):1199-1210
pubmed: 29228477
Nat Rev Dis Primers. 2018 Jun 21;4(1):1
pubmed: 29930242
Hautarzt. 2018 Oct;69(10):794-800
pubmed: 30215114
Hautarzt. 2019 Jan;70(1):21-28
pubmed: 29876613
J Eur Acad Dermatol Venereol. 2019 Jan;33(1):151-156
pubmed: 30067284